Clinical Trial Update: Efficacy and Safety Study of ZOMETA® in Treatment of High-level NTX Non Small Cell Lung Cancer With Bone Metastasis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the efficacy and safety of ZOMETA (zoledronic acid) in patients with non-small cell lung cancer with bone metastases and hig…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Metastases
• Non-small Cell Lung Cancer

Drugs mentioned

• Zometa (Zoledronic acid)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Non Small Cell Lung Cancer, Bone Metastases | Phase 4 | Status: COMPLETED